InvestorsHub Logo
Followers 0
Posts 54
Boards Moderated 0
Alias Born 09/14/2016

Re: None

Thursday, 05/31/2018 4:32:14 PM

Thursday, May 31, 2018 4:32:14 PM

Post# of 3353
I initially didn't realize how deeply connected Right to Try and BCLI are, but when you look into it, Matt (the Matthew the President was talking to during the press conference) is Matt Bellina and he's been fighting with ALSA specifically about funding BCLI and making sure this treatment is available fast enough so ALS fast progressors aren't certain to die before FDA approval can be accomplished.

The question now for Brainstorm is can they manage phase 3 and help fast progressors outside the clinical trial at the same time. Maybe City of Hope, the Mayo Clinic and others involved in phase 3 will be able to help.

For me the bottom line is I think their technology works and given it is the patient's own stem cells, not some synthetic drug compound, the risk / reward for ALS patients looks to be in favor of allowing treatment.

Of course, right to try is about more than BCLI and I'm sure there will be some abuses, but for ALS and NurOwn, I think we are looking at a life changing treatment that has proven itself safe in phase 1, 2 and so far in 3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News